Skip to main content
MDAI
NASDAQ Industrial Applications And Services

Spectral AI Appoints Vincent S. Capone as CEO, Dissolves Office of Chairman

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.56
Mkt Cap
$47.875M
52W Low
$1.04
52W High
$3.21
52W Position info
50% above low
Off High info
51% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

MDAI sits 50% above its 52-week low of $1.04.

Summary

Spectral AI has promoted Vincent S. Capone from CFO and General Counsel to Chief Executive Officer, effective immediately, as the company prepares for commercialization of its DeepView System. The Office of the Chairman was dissolved, with Dr. J. Michael DiMaio becoming Executive Chairman.


Key Events · Executive and Board Changes · MDAI

  • New Chief Executive Officer Appointed

    Vincent S. Capone, previously CFO and General Counsel, has been appointed Chief Executive Officer, effective February 9, 2026. He has an extensive background in law, accounting, finance, and operations management.

  • Office of the Chairman Dissolved

    The Board of Directors dissolved the Office of the Chairman on February 9, 2026. Dr. J. Michael DiMaio, who previously led the Office of the Chairman, will now serve as Executive Chairman.

  • Strategic Leadership for Commercialization

    Mr. Capone's appointment is highlighted as a strategic move as Spectral AI transitions towards the commercialization of its proprietary DeepView System, an AI-driven burn wound assessment device.


Analysis · MDAI · Industrial Applications And Services

Spectral AI, a small-cap company focused on AI-driven medical diagnostics, has appointed Vincent S. Capone as its new Chief Executive Officer. Capone, who previously served as the company's Chief Financial Officer and General Counsel, brings a strong background in finance, law, and operations, which is critical as the company transitions towards commercialization of its DeepView System. This internal promotion suggests a strategic and stable leadership transition. Concurrently, the Board dissolved the Office of the Chairman, with Dr. J. Michael DiMaio, the former Chairman, assuming the role of Executive Chairman, indicating a restructured leadership framework. This follows the recent departure of the Chief Commercial Officer on February 3, 2026, suggesting a broader executive realignment as the company prepares for market entry.

At the time of this filing, MDAI was trading at $1.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $47.9M. The 52-week trading range was $1.04 to $3.21. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDAI - Latest Insights

MDAI
Jul 08, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.73
Real-time Price: $1.67 info
Change: -$0.0603 (-3%) info
Market Cap: $52.191M info
MDAI
Jun 01, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.03
Real-time Price: $1.67 info
Change: -$0.3603 (-18%) info
Market Cap: $52.191M info
MDAI
May 26, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.37
Real-time Price: $1.67 info
Change: -$0.7003 (-30%) info
Market Cap: $52.191M info
MDAI
May 26, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.93
Real-time Price: $1.67 info
Change: -$1.26 (-43%) info
Market Cap: $52.191M info
MDAI
May 13, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.14
Real-time Price: $1.67 info
Change: -$0.4699 (-22%) info
Market Cap: $52.191M info